Rolf Bohlmann

947 total citations
28 papers, 541 citations indexed

About

Rolf Bohlmann is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Rolf Bohlmann has authored 28 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Rolf Bohlmann's work include Steroid Chemistry and Biochemistry (5 papers), Sesquiterpenes and Asteraceae Studies (3 papers) and Estrogen and related hormone effects (3 papers). Rolf Bohlmann is often cited by papers focused on Steroid Chemistry and Biochemistry (5 papers), Sesquiterpenes and Asteraceae Studies (3 papers) and Estrogen and related hormone effects (3 papers). Rolf Bohlmann collaborates with scholars based in Germany, South Africa and Mexico. Rolf Bohlmann's co-authors include Olaf Schaefer, M. Hümpel, Wolf‐Dieter Schleuning, Ferdinand Bohlmann, Karl‐Heinrich Fritzemeier, Jack E. Baldwin, Johann Mulzer, Christa Zdero, Simon G. Alcock and Harold Robinson and has published in prestigious journals such as Angewandte Chemie International Edition, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Rolf Bohlmann

26 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rolf Bohlmann Germany 12 221 204 128 89 66 28 541
Michael N. Gould United States 9 381 1.7× 61 0.3× 58 0.5× 132 1.5× 75 1.1× 12 607
Heather E. Kleiner United States 19 457 2.1× 103 0.5× 189 1.5× 110 1.2× 45 0.7× 23 815
Daulat Bikram Khadka South Korea 17 352 1.6× 373 1.8× 83 0.6× 103 1.2× 48 0.7× 34 879
Y. R. Santosh Laxmi United States 16 323 1.5× 225 1.1× 105 0.8× 90 1.0× 241 3.7× 31 747
Dimitar Jakimov Serbia 17 262 1.2× 299 1.5× 76 0.6× 101 1.1× 158 2.4× 69 711
Margaret Gaskell United Kingdom 14 286 1.3× 117 0.6× 54 0.4× 80 0.9× 67 1.0× 17 579
Jinhong Feng China 18 471 2.1× 239 1.2× 56 0.4× 152 1.7× 41 0.6× 52 818
Prabu Devanesan United States 11 362 1.6× 98 0.5× 58 0.5× 79 0.9× 246 3.7× 15 698
H. Ishizaki United States 10 255 1.2× 37 0.2× 138 1.1× 79 0.9× 20 0.3× 17 502
Deanne M. Dulik United States 16 409 1.9× 74 0.4× 164 1.3× 120 1.3× 24 0.4× 26 710

Countries citing papers authored by Rolf Bohlmann

Since Specialization
Citations

This map shows the geographic impact of Rolf Bohlmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf Bohlmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf Bohlmann more than expected).

Fields of papers citing papers by Rolf Bohlmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rolf Bohlmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf Bohlmann. The network helps show where Rolf Bohlmann may publish in the future.

Co-authorship network of co-authors of Rolf Bohlmann

This figure shows the co-authorship network connecting the top 25 collaborators of Rolf Bohlmann. A scholar is included among the top collaborators of Rolf Bohlmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rolf Bohlmann. Rolf Bohlmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lücking, Ulrich, Dirk Kosemund, Niels Böhnke, et al.. (2021). Changing for the Better: Discovery of the Highly Potent and Selective CDK9 Inhibitor VIP152 Suitable for Once Weekly Intravenous Dosing for the Treatment of Cancer. Journal of Medicinal Chemistry. 64(15). 11651–11674. 53 indexed citations
2.
Bohlmann, Rolf, et al.. (2016). Preparation of Aldehydes by Oxidation of Benzylic Amines with Selectfluor™ (F-TEDA-BF4). Synlett. 27(12). 1870–1872. 4 indexed citations
3.
Hartung, Ingo V., Stefanie Hammer, Roland Neuhaus, et al.. (2015). Optimization of allosteric MEK inhibitors. Part 2: Taming the sulfamide group balances compound distribution properties. Bioorganic & Medicinal Chemistry Letters. 26(1). 186–193. 5 indexed citations
4.
Otto, Christiane, Iris Fuchs, Rolf Bohlmann, et al.. (2008). In vivo characterization of estrogen receptor modulators with reduced genomic versus nongenomic activity in vitro. The Journal of Steroid Biochemistry and Molecular Biology. 111(1-2). 95–100. 19 indexed citations
5.
Thierauch, Karl‐Heinz, Martin Haberey, Holger Hess‐Stumpp, et al.. (2007). ZK 261991. a novel VEGFR inhibitor for tumor therapy. Cancer Research. 67. 2135–2135. 1 indexed citations
6.
Schaefer, Olaf, Rolf Bohlmann, Wolf‐Dieter Schleuning, Kai Schulze‐Forster, & M. Hümpel. (2005). Development of a Radioimmunoassay for the Quantitative Determination of 8-Prenylnaringenin in Biological Matrices. Journal of Agricultural and Food Chemistry. 53(8). 2881–2889. 40 indexed citations
7.
Hoffmann, Jens, Rolf Bohlmann, H. Hofmeister, et al.. (2004). Characterization of New Estrogen Receptor Destabilizing Compounds: Effects on Estrogen-Sensitive and Tamoxifen-Resistant Breast Cancer. JNCI Journal of the National Cancer Institute. 96(3). 210–218. 66 indexed citations
8.
Schaefer, Olaf, M. Hümpel, Karl‐Heinrich Fritzemeier, Rolf Bohlmann, & Wolf‐Dieter Schleuning. (2003). 8-Prenyl naringenin is a potent ERα selective phytoestrogen present in hops and beer. The Journal of Steroid Biochemistry and Molecular Biology. 84(2-3). 359–360. 87 indexed citations
10.
Mulzer, Johann & Rolf Bohlmann. (2000). The Role of Natural Products in Drug Discovery. 19 indexed citations
11.
Bohlmann, Rolf & P. Strehlke. (1996). Synthesis of functionalized 1-vinylazoles by a novel wittig reaction of 1-acylazoles. Tetrahedron Letters. 37(40). 7249–7250. 3 indexed citations
12.
Bohlmann, Rolf. (1994). A new route to steroidal vinyl fluorides. Tetrahedron Letters. 35(1). 85–88. 5 indexed citations
13.
Bull, James R., et al.. (1994). Cycloaddition mediated synthesis and rearrangement of 16-functionalised 14α,17α-etheno-19-norsteroids. Tetrahedron. 50(21). 6347–6362. 4 indexed citations
14.
Bohlmann, Rolf. (1992). The Folding of Squalene; An Old Problem has New Results. Angewandte Chemie International Edition in English. 31(5). 582–584. 11 indexed citations
15.
Bohlmann, Rolf. (1992). Squalenfaltung, ein alter Bekannter?. Angewandte Chemie. 104(5). 596–598. 4 indexed citations
16.
Jungblut, P. W., et al.. (1989). Receptor deprivation with unimpaired edema formation in porcine uteri by "dissociated estrogens". European Journal of Endocrinology. 120(3_Suppl). S160–S161. 1 indexed citations
17.
Alcock, Simon G., Jack E. Baldwin, Rolf Bohlmann, Laurence M. Harwood, & Jeffrey I. Seeman. (1985). On the conjugative isomerizations of .beta.,.gamma.-unsaturated esters. Stereochemical generalizations and predictions for 1,3-prototropic shifts under basic conditions. The Journal of Organic Chemistry. 50(19). 3526–3535. 44 indexed citations
18.
Bohlmann, Ferdinand, Christa Zdero, Rolf Bohlmann, Robert M. King, & Harold Robinson. (1980). Neue sesquiterpene aus Liabum-arten. Phytochemistry. 19(4). 579–582. 46 indexed citations
19.
Domínguez, Xorge A., et al.. (1980). A Pseudoguaianolide from Hymenoxys linearifolia. Phytochemistry. 19(10). 2204–2205. 6 indexed citations
20.
Bohlmann, Ferdinand & Rolf Bohlmann. (1980). A caryophyllene derivative from Leucanthemum maximum. Phytochemistry. 19(11). 2469–2470. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026